Welcome to KOELIS®
Please choose a country or region.
KOELIS® develops innovative technologies that help urologists and radiologists from around the world in their routine clinical practice. We’re focused on innovation and bringing to market new solutions for enhancing prostate cancer care. Our team is committed to helping physicians offer the most personalized, appropriate treatment for patients while preserving their quality of life.
Thanks to cutting-edge imaging tools like KOELIS Trinity® prostate fusion biopsy system, which combines multiple imaging modalities with full 3D ultrasound and Organ-Based Tracking Fusion® technology, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach that enhances diagnostic confidence.
The team at KOELIS® innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging. With global headquaters in Grenoble, France and other offices in Princeton, NJ and Hong Kong, and Homberg Germany, KOELIS® technology has been featured in more than 80 clinical publications and used to treat more than 350,000 patients worldwide.
KOELIS® mission is to provide clinicians with quality control at every step of the prostate cancer management and to streamline workflow by providing a patient-tailored, high-detailed, updatable prostate cartography that is stored and shared for promoting multidisciplinary shared decisions. Based on the value of 3D imaging, organ-based tracking fusion® and mapping, KOELIS® helps urologists and radiologists to gain confidence and precision in diagnosis and active surveillance as well as planning and performing guided targeted treatments.
© 2022 KOELIS®. All rights reserved. KOELIS Trinity® is a registered trademark of KOELIS® in certain countries.